T2* Mapping for quantitative assessment of placental function and oxygenation

Case ID:
1991
Web Published:
3/14/2016
Description:

Despite recent focus, including the announcement of the NIH Human Placenta Project, on placental health and function as a primary driver of fetal growth and development, current in vivo identification and assessment of abnormal placentation is limited. This MRI protocol and modeling methodology, which uses an endogeneous contrast agent and therefore is non-invasive, facilitates assessment of oxygenation and blood flow in the placenta. This technique could be used in pregnancies complicated by preeclampsia, preterm labor, intrauterine growth restriction, diabetes mellitus, chronic hypertension and other high risk conditions associated with abnormal placentation.

Patent Information:
Category(s):
Diagnostics
Imaging
For Information, Contact:
Trina Voss
Technology Development Manager
Oregon Health & Science University
503-494-8200
vosst@ohsu.edu
Inventors:
Matthias Schabel
Antonio Frias
Christopher Kroenke
Keywords:
Diagnostics
Imaging
Imaging - MRI
© 2018. All Rights Reserved. Powered by Inteum